131 related articles for article (PubMed ID: 26781548)
1. Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.
Johansen RF; Søndergaard E; Sørensen LP; Jurik AG; Christiansen JS; Nielsen S
Diabetologia; 2016 Apr; 59(4):833-43. PubMed ID: 26781548
[TBL] [Abstract][Full Text] [Related]
2. Measuring VLDL1-Triglyceride and VLDL2-Triglyceride Kinetics in Men: Effects of Dietary Control on Day-to-Day Variability.
Johansen RF; Søndergaard E; Sørensen LP; Jurik AG; Nielsen S
Horm Metab Res; 2017 Aug; 49(8):604-611. PubMed ID: 28561184
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
4. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia.
Adiels M; Borén J; Caslake MJ; Stewart P; Soro A; Westerbacka J; Wennberg B; Olofsson SO; Packard C; Taskinen MR
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1697-703. PubMed ID: 15947244
[TBL] [Abstract][Full Text] [Related]
5. Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.
Vergès B; Florentin E; Baillot-Rudoni S; Monier S; Petit JM; Rageot D; Gambert P; Duvillard L
Diabetologia; 2008 Aug; 51(8):1382-90. PubMed ID: 18535816
[TBL] [Abstract][Full Text] [Related]
6. Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production.
Yildirim V; Ter Horst KW; Gilijamse PW; van Harskamp D; Schierbeek H; Jansen H; Schimmel AW; Nieuwdorp M; Groen AK; Serlie MJ; van Riel NA; Dallinga-Thie GM
JCI Insight; 2023 Aug; 8(16):. PubMed ID: 37432744
[TBL] [Abstract][Full Text] [Related]
7. Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects.
Gill JM; Brown JC; Bedford D; Wright DM; Cooney J; Hughes DA; Packard CJ; Caslake MJ
Atherosclerosis; 2004 Sep; 176(1):49-56. PubMed ID: 15306174
[TBL] [Abstract][Full Text] [Related]
8. Metabolic basis of hypotriglyceridemic effects of insulin in normal men.
Malmström R; Packard CJ; Watson TD; Rannikko S; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1454-64. PubMed ID: 9261280
[TBL] [Abstract][Full Text] [Related]
9. Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men.
Johansen RF; Søndergaard E; Sørensen LP; Nellemann B; Christiansen JS; Nielsen S
Diabetologia; 2015 Feb; 58(2):355-62. PubMed ID: 25385409
[TBL] [Abstract][Full Text] [Related]
10. Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes.
Johanson EH; Jansson PA; Gustafson B; Lönn L; Smith U; Taskinen MR; Axelsen M
J Intern Med; 2004 Feb; 255(2):273-9. PubMed ID: 14746565
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Diabetes; 1998 May; 47(5):779-87. PubMed ID: 9588450
[TBL] [Abstract][Full Text] [Related]
12. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
Taskinen MR; Matikainen N; Björnson E; Söderlund S; Inkeri J; Hakkarainen A; Parviainen H; Sihlbom C; Thorsell A; Andersson L; Adiels M; Packard CJ; Borén J
Diabetologia; 2023 Dec; 66(12):2307-2319. PubMed ID: 37775612
[TBL] [Abstract][Full Text] [Related]
13. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.
Adiels M; Westerbacka J; Soro-Paavonen A; Häkkinen AM; Vehkavaara S; Caslake MJ; Packard C; Olofsson SO; Yki-Järvinen H; Taskinen MR; Borén J
Diabetologia; 2007 Nov; 50(11):2356-65. PubMed ID: 17849096
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.
Ooi EM; Chan DC; Hodson L; Adiels M; Boren J; Karpe F; Fielding BA; Watts GF; Barrett PH
Eur J Clin Invest; 2016 Aug; 46(8):730-6. PubMed ID: 27378472
[TBL] [Abstract][Full Text] [Related]
15. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.
Sørensen LP; Andersen IR; Søndergaard E; Gormsen LC; Schmitz O; Christiansen JS; Nielsen S
Diabetes; 2011 Jan; 60(1):88-96. PubMed ID: 20858686
[TBL] [Abstract][Full Text] [Related]
16. Moderate Exercise Increases Affinity of Large Very Low-Density Lipoproteins for Hydrolysis by Lipoprotein Lipase.
Ghafouri K; Cooney J; Bedford DK; Wilson J; Caslake MJ; Gill JM
J Clin Endocrinol Metab; 2015 Jun; 100(6):2205-13. PubMed ID: 25867814
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
Demant T; Gaw A; Watts GF; Durrington P; Buckley B; Imrie CW; Wilson C; Packard CJ; Shepherd J
J Lipid Res; 1993 Jan; 34(1):147-56. PubMed ID: 8445339
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
19. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.
Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Diabetologia; 1997 Apr; 40(4):454-62. PubMed ID: 9112023
[TBL] [Abstract][Full Text] [Related]
20. A novel method for measuring intestinal and hepatic triacylglycerol kinetics.
Sun F; Stolinski M; Shojaee-Moradie F; Lou S; Ma Y; Hovorka R; Umpleby AM
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E1041-7. PubMed ID: 23592484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
